A method according to claim 1, wherein the agent is an agent which is capable of substantially preventing or reducing pain, tenderness or hardness in pericranial muscle induced by intra muscular infusion of algogenic substances, or preventing or normalizing a qualitatively altered stimulus-response function induced by intra muscular infusion of algogenic substances